| Name | Title | Contact Details |
|---|
Copies - FYI is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Salus Surgical Group is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MEDO USA is a Roselle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BrightSpring Health Services is the new name for Kentucky-based ResCare, the parent company of a family of brands and services that provides both clinical and nonclinical habilitative care services for people of all ages and health and skill levels, across home and community settings. As care preferences and health care needs are changing, BrightSpring`s new name reflects the company`s evolution that began nearly two years ago to successfully meet the multifaceted and multidisciplinary requirements of the populations it serves amid this changing health care landscape. The path forward at BrightSpring is occurring through investments in capabilities, people, processes and technology to create an unprecedented and differentiated platform of innovative solutions that improve health outcomes and lower costs for complex populations and payer systems. ResCare has a rich history of more than 44 years – making a difference in the communities that it serves and helping people live their best lives. While celebrating the successful history, BrightSpring is repositioning itself for the future of health care. Its vision is to be the leading provider of comprehensive home and community-based health services to complex populations.
At PRA Health Sciences, providing innovative solutions for our clients is what we do. Side by side with our clients, we strive to move drug discovery forward, helping develop life-saving and life-improving drugs. PRA has more than 10,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. As a top five CRO, we have worked on 100 plus marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50 plus such drugs.